ResMed Partners EDB to Expand Singapore Operations
ResMed Partners EDB to Expand Singapore Operations
These investments and partnerships will boost ResMed's advancements in sleep health, breathing health, and home health technology.The company will increase its production capacity and advance its technology in Singapore.
公司將在新加坡增加生產能力並提升其科技。
ResMed has partnered with the Singapore Economic Development Board (EDB) to expand its operations in Singapore.
瑞思邁已與新加坡經濟發展局（EDB）合作，擴大了在新加坡的業務。
As part of its new investments in Singapore in 2029, ResMed will boost its production capacity, drive advanced manufacturing process innovation, and support the growth of its Digital Science and Artificial Intelligence (AI) Lab (DSAIL).
作爲瑞思邁在2029年在新加坡的新投資的一部分，將增加其生產能力，推動先進製造流程創新，並支持其數字科學和人工智能實驗室（DSAIL）的增長。
These investments and partnerships will boost ResMed's advancements in sleep health, breathing health, and home health technology.
"We have been in Singapore for over two decades, and this EDB partnership reflects our ongoing commitment to leveraging Singapore's exceptional digital infrastructure, talent, and technology to help us achieve our goal of improving the lives of 500 million people by 2030," Mick Farrell, CEO of ResMed said.
這些投資和合作將推動瑞思邁在睡眠健康、呼吸健康和家庭健康技術方面的進展。
「我們在新加坡已有20多年的歷史，這個與EDb的合作反映了我們持續利用新加坡卓越的數字基礎設施、人才和技術的承諾，幫助我們實現到2030年改善50000萬人生活的目標，」瑞思邁CEO Mick Farrell表示。
ResMed currently provides 1,300 jobs in Singapore.
瑞思邁目前在新加坡提供1300個就業崗位。
